Maravai LifeSciences Holdings Inc reports results for the quarter ended in December - Earnings Summary

Maravai Lifesciences Holdings

23/02/2022 23:49

* Maravai LifeSciences Holdings Inc  MRVI.OQ  reported
quarterly
adjusted earnings of 45 cents​​ per share for the quarter ended
in December. The mean expectation of nine analysts for the
quarter was for earnings of 38 cents per share.
    * Revenue rose 132.3% to $228.44 million from a year ago; 
analysts expected $208.09 million. 
    * Maravai LifeSciences Holdings Inc's reported EPS for the
quarter
was 42 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Maravai LifeSciences Holdings Inc shares had fallen
by 18.8%
this quarter.
    * The company reported quarterly net income of $55.83
million.
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $57.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated February 23 at 11:48 p.m.
 ​All figures in US dollars unless otherwise stated